Floatz logo

DEXKETOPROFEN

Cancer of Endometrium

Peking University People's HospitalSmall moleculePhase 3Active
B
60/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
45/ 100
Competitive Position
95/ 100

Competitive context

3 Active assets in the Cancer of Endometrium cohort.

Asset / SponsorPhaseRating
METAMIZOLE
Peking University People's Hospital
Phase 3B
NEPENTHE
Peking University People's Hospital
Phase 3B
TEONANACATL
Psyence Australia Pty Ltd
Phase 2CCC

Same molecule, other indications

DEXKETOPROFEN is also rated in:

migraine disorderDormant
BBB
Indicative ·
73 / 100
View asset →
migraine without auraDormant
BB
Indicative ·
68 / 100
View asset →
Carcinoma, HepatocellularDormant
BB
Indicative ·
67 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →